Abstract | BACKGROUND: METHODS: Biliary lipid composition and the clinical course of AGS and PFIC patients were examined before and after PEBD. RESULTS: Pre-PEBD bile from AGS patients had greater chenodeoxycholic/ cholic acid (CDCA/CA), bile salt, cholesterol and phospholipid concentrations than PFIC patients. AGS patients, and PFIC patients with familial intrahepatic cholestasis 1 (FIC1) genotype, responded better to PEBD than PFIC patients with bile salt export protein (BSEP) genotype. After successful PEBD, AGS patients have higher biliary lipid concentrations than PFIC patients and PEBD also increases biliary phospholipid concentrations in FIC1 patients. CONCLUSION: Both AGS and FIC1 patients can benefit from PEBD, and preserved biliary phospholipid concentrations may be associated with better outcomes post-PEBD.
|
Authors | Karan M Emerick, Marc S Elias, Hector Melin-Aldana, Sandra Strautnieks, Richard J Thompson, Laura N Bull, A s Knisely, Peter F Whitington, Richard M Green |
Journal | BMC gastroenterology
(BMC Gastroenterol)
Vol. 8
Pg. 47
(Oct 20 2008)
ISSN: 1471-230X [Electronic] England |
PMID | 18937870
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Chemical References |
- Phospholipids
- Chenodeoxycholic Acid
- Cholesterol
- Cholic Acid
|
Topics |
- Adolescent
- Alagille Syndrome
(genetics, metabolism)
- Bile
(metabolism)
- Bile Ducts, Intrahepatic
(surgery)
- Biopsy
- Chenodeoxycholic Acid
(metabolism)
- Child
- Child, Preschool
- Cholestasis, Intrahepatic
(genetics, metabolism)
- Cholesterol
(metabolism)
- Cholic Acid
(metabolism)
- Digestive System Surgical Procedures
(methods)
- Disease Progression
- Gallbladder
(surgery)
- Humans
- Infant
- Lipid Metabolism
(physiology)
- Liver
(pathology)
- Phospholipids
(metabolism)
- Treatment Outcome
|